Predictive Oncology

Predictive Oncology is a knowledge-driven company disrupting the oncology drug discovery paradigm to increase the probability of success of drug candidates during clinical development. The goal is to help biopharma develop the right therapy for the right patient leading to more effective treatments and improved patient outcomes. Powered by AI, Predictive Oncology leverages a biobank of 150,000+ cancer tumors, categorized by patient type, to predict drug response in a heterogeneous population against early stage drug compounds. The outcome enables partners to increase the probability of success of drug candidates in clinical trials and narrow down the tumor indications to be most likely to succeed.